Cytonics Announces Successful Completion of Phase 1 Study for First Nine Patients in CYT-108 Clinical Trial
Hand-out
Press Releases
January 21, 2025

Cytonics Announces Successful Completion of Phase 1 Study for First Nine Patients in CYT-108 Clinical Trial

– No adverse events reported; CYT-108 progressing as a potential disease-modifying therapy for osteoarthritis –

bradford

The Bradford Era

Local & Social